G Mark Foletta
Affiliations
- Director at Enanta Pharmaceuticals Inc (ENTA), 2024-03-08
- Director at Amn Healthcare Services Inc (AMN), 2024-03-01
- Director at Dexcom Inc (DXCM), 2023-05-22
- Evp & Chief Financial Officer at Tocagen Inc (TOCA), 2019-10-05
- Director at Regulus Therapeutics Inc. (RGLS), 2017-12-07
- Interim Cfo at Biocept Inc (BIOC), 2015-09-02
- Director at Ambit Biosciences Corp (AMBI), 2014-11-12
- Svp, Chief Financial Officer at Amylin Pharmaceuticals Inc (AMLN), 2012-08-10
- Director at Anadys Pharmaceuticals Inc (ANDS), 2011-05-27
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| AMN | $56.90 | 500 | Director | 8,573 | 2024-02-29 | Filing | |
| TOCA | $4.30 | 5,000 | Officer | 15,042 | 2019-05-28 | Filing | |
| TOCA | $10.00 | 5,000 | Officer | 5,000 | 2017-04-19 | Filing | |
| RGLS | $7.64 | 10,000 | Director | 10,000 | 2015-08-13 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| AMN | $88.78 | 1,458 | Director | 8,073 | 2023-04-21 | Filing | |
| AMN | $84.63 | 1,053 | Director | 8,073 | 2023-04-11 | Filing | |
| AMN | $84.29 | 4,989 | Director | 9,126 | 2023-04-11 | Filing | |
| DXCM | $569.54 | 41 | Director | 12,597 | 2021-12-01 | Filing | |
| DXCM | $567.35 | 2 | Director | 12,638 | 2021-12-01 | Filing |